600998.SS
600998.SS
CNE100000W45
JOINTOWN PHARMACEUTICAL GROUP C
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 161.389.993.007 151.809.798.857
6.3%
Cost of Revenue 148.840.428.201 139.967.716.268
6.3%
Gross Profit 12.549.564.806 11.842.082.589
6.0%
8.506.116.503 7.628.517.752
11.5%
Operating Income 4.043.448.303 4.213.564.837
4.0%
Pretax Income 3.289.816.562 3.637.468.778
9.6%
Net Income Common Stockholders 2.254.863.863 2.507.391.944
10.1%
-- --
--
-- --
--
ende